APO Research

APO RESEARCH · REPORT

Sevoflurane

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

Product & engineering

Understand the product.

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Selected research

Market Analysis & Forecast

Global Sevoflurane Market Analysis and Forecast 2026-2032

Market perspective

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.

Read the full market overview

The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.

This report presents an overview of global market for Sevoflurane, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sevoflurane, also provides the consumption of main regions and countries. Of the upcoming market potential for Sevoflurane, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sevoflurane sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sevoflurane market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sevoflurane sales, projected growth trends, production technology, application and end-user industry.

Sevoflurane Segment by Company

Abbott

Baxter

Maruishi

Jiangsu Hengrui

Lunan

Sevoflurane Segment by Type

Generic Drug

Original Drug

Sevoflurane Segment by Application

Hospitals

Other Medical Institutions

Sevoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sevoflurane production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Sevoflurane in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sevoflurane Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Generic Drug Major Manufacturers Table 3. Original Drug Major Manufacturers Table 4. Global Sevoflurane Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Other Medical Institutions Major Manufacturers Table 7. Sevoflurane Industry Trends Table 8. Sevoflurane Industry Drivers Table 9. Sevoflurane Industry Opportunities and Challenges Table 10. Sevoflurane Industry Restraints Table 11. Global Sevoflurane Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K t) Table 12. Global Sevoflurane Production by Region (2021-2026) & (K t) Table 13. Global Sevoflurane Production by Region (2027-2032) & (K t) Table 14. Global Sevoflurane Production Market Share by Region (2021-2026) Table 15. Global Sevoflurane Production Market Share by Region (2027-2032) Table 16. Global Sevoflurane Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Sevoflurane Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Sevoflurane Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Sevoflurane Revenue Market Share by Region (2021-2026) Table 20. Global Sevoflurane Revenue Market Share by Region (2027-2032) Table 21. Global Sevoflurane Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K t) Table 22. Global Sevoflurane Sales by Region (2021-2026) & (K t) Table 23. Global Sevoflurane Sales by Region (2027-2032) & (K t) Table 24. Global Sevoflurane Sales Market Share by Region (2021-2026) Table 25. Global Sevoflurane Sales Market Share by Region (2027-2032) Table 26. Global Sevoflurane Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Sevoflurane Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Sevoflurane Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Sevoflurane Sales Market Share by Manufacturers (2021-2026) Table 30. Global Sevoflurane Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 31. Global Sevoflurane Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Sevoflurane Manufacturers, Product Type & Application Table 34. Global Sevoflurane Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Sevoflurane by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Sevoflurane Revenue Market Share by Type (2021-2026) Table 40. Global Sevoflurane Revenue Market Share by Type (2027-2032) Table 41. Global Sevoflurane Sales by Type (2021-2026) & (K t) Table 42. Global Sevoflurane Sales by Type (2027-2032) & (K t) Table 43. Global Sevoflurane Sales Market Share by Type (2021-2026) Table 44. Global Sevoflurane Sales Market Share by Type (2027-2032) Table 45. Global Sevoflurane Price by Type (2021-2026) & (USD/Unit) Table 46. Global Sevoflurane Price by Type (2027-2032) & (USD/Unit) Table 47. Global Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Sevoflurane Revenue Market Share by Application (2021-2026) Table 50. Global Sevoflurane Revenue Market Share by Application (2027-2032) Table 51. Global Sevoflurane Sales by Application (2021-2026) & (K t) Table 52. Global Sevoflurane Sales by Application (2027-2032) & (K t) Table 53. Global Sevoflurane Sales Market Share by Application (2021-2026) Table 54. Global Sevoflurane Sales Market Share by Application (2027-2032) Table 55. Global Sevoflurane Price by Application (2021-2026) & (USD/Unit) Table 56. Global Sevoflurane Price by Application (2027-2032) & (USD/Unit) Table 57. Abbott Company Information Table 58. Abbott Business Overview Table 59. Abbott Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 60. Abbott Sevoflurane Product Portfolio Table 61. Abbott Recent Development Table 62. Baxter Company Information Table 63. Baxter Business Overview Table 64. Baxter Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 65. Baxter Sevoflurane Product Portfolio Table 66. Baxter Recent Development Table 67. Maruishi Company Information Table 68. Maruishi Business Overview Table 69. Maruishi Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. Maruishi Sevoflurane Product Portfolio Table 71. Maruishi Recent Development Table 72. Jiangsu Hengrui Company Information Table 73. Jiangsu Hengrui Business Overview Table 74. Jiangsu Hengrui Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Jiangsu Hengrui Sevoflurane Product Portfolio Table 76. Jiangsu Hengrui Recent Development Table 77. Lunan Company Information Table 78. Lunan Business Overview Table 79. Lunan Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Lunan Sevoflurane Product Portfolio Table 81. Lunan Recent Development Table 82. North America Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Sevoflurane Sales by Type (2021-2026) & (K t) Table 85. North America Sevoflurane Sales by Type (2027-2032) & (K t) Table 86. North America Sevoflurane Sales Price by Type (2021-2026) & (USD/Unit) Table 87. North America Sevoflurane Sales Price by Type (2027-2032) & (USD/Unit) Table 88. North America Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Sevoflurane Sales by Application (2021-2026) & (K t) Table 91. North America Sevoflurane Sales by Application (2027-2032) & (K t) Table 92. North America Sevoflurane Sales Price by Application (2021-2026) & (USD/Unit) Table 93. North America Sevoflurane Sales Price by Application (2027-2032) & (USD/Unit) Table 94. North America Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K t) Table 98. North America Sevoflurane Sales by Country (2021-2026) & (K t) Table 99. North America Sevoflurane Sales by Country (2027-2032) & (K t) Table 100. North America Sevoflurane Sales Price by Country (2021-2026) & (USD/Unit) Table 101. North America Sevoflurane Sales Price by Country (2027-2032) & (USD/Unit) Table 102. United States Sevoflurane Revenue (2021-2032) & (US$ Million) Table 103. Canada Sevoflurane Revenue (2021-2032) & (US$ Million) Table 104. Mexico Sevoflurane Revenue (2021-2032) & (US$ Million) Table 105. Europe Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Sevoflurane Sales by Type (2021-2026) & (K t) Table 108. Europe Sevoflurane Sales by Type (2027-2032) & (K t) Table 109. Europe Sevoflurane Sales Price by Type (2021-2026) & (USD/Unit) Table 110. Europe Sevoflurane Sales Price by Type (2027-2032) & (USD/Unit) Table 111. Europe Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Sevoflurane Sales by Application (2021-2026) & (K t) Table 114. Europe Sevoflurane Sales by Application (2027-2032) & (K t) Table 115. Europe Sevoflurane Sales Price by Application (2021-2026) & (USD/Unit) Table 116. Europe Sevoflurane Sales Price by Application (2027-2032) & (USD/Unit) Table 117. Europe Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K t) Table 121. Europe Sevoflurane Sales by Country (2021-2026) & (K t) Table 122. Europe Sevoflurane Sales by Country (2027-2032) & (K t) Table 123. Europe Sevoflurane Sales Price by Country (2021-2026) & (USD/Unit) Table 124. Europe Sevoflurane Sales Price by Country (2027-2032) & (USD/Unit) Table 125. Germany Sevoflurane Revenue (2021-2032) & (US$ Million) Table 126. France Sevoflurane Revenue (2021-2032) & (US$ Million) Table 127. U.K. Sevoflurane Revenue (2021-2032) & (US$ Million) Table 128. Italy Sevoflurane Revenue (2021-2032) & (US$ Million) Table 129. Russia Sevoflurane Revenue (2021-2032) & (US$ Million) Table 130. Spain Sevoflurane Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Sevoflurane Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Sevoflurane Revenue (2021-2032) & (US$ Million) Table 133. Sweden Sevoflurane Revenue (2021-2032) & (US$ Million) Table 134. Poland Sevoflurane Revenue (2021-2032) & (US$ Million) Table 135. China Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 136. China Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 137. China Sevoflurane Sales by Type (2021-2026) & (K t) Table 138. China Sevoflurane Sales by Type (2027-2032) & (K t) Table 139. China Sevoflurane Sales Price by Type (2021-2026) & (USD/Unit) Table 140. China Sevoflurane Sales Price by Type (2027-2032) & (USD/Unit) Table 141. China Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 142. China Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 143. China Sevoflurane Sales by Application (2021-2026) & (K t) Table 144. China Sevoflurane Sales by Application (2027-2032) & (K t) Table 145. China Sevoflurane Sales Price by Application (2021-2026) & (USD/Unit) Table 146. China Sevoflurane Sales Price by Application (2027-2032) & (USD/Unit) Table 147. Asia Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Sevoflurane Sales by Type (2021-2026) & (K t) Table 150. Asia Sevoflurane Sales by Type (2027-2032) & (K t) Table 151. Asia Sevoflurane Sales Price by Type (2021-2026) & (USD/Unit) Table 152. Asia Sevoflurane Sales Price by Type (2027-2032) & (USD/Unit) Table 153. Asia Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Sevoflurane Sales by Application (2021-2026) & (K t) Table 156. Asia Sevoflurane Sales by Application (2027-2032) & (K t) Table 157. Asia Sevoflurane Sales Price by Application (2021-2026) & (USD/Unit) Table 158. Asia Sevoflurane Sales Price by Application (2027-2032) & (USD/Unit) Table 159. Asia Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K t) Table 163. Asia Sevoflurane Sales by Country (2021-2026) & (K t) Table 164. Asia Sevoflurane Sales by Country (2027-2032) & (K t) Table 165. Asia Sevoflurane Sales Price by Country (2021-2026) & (USD/Unit) Table 166. Asia Sevoflurane Sales Price by Country (2027-2032) & (USD/Unit) Table 167. Japan Sevoflurane Revenue (2021-2032) & (US$ Million) Table 168. South Korea Sevoflurane Revenue (2021-2032) & (US$ Million) Table 169. India Sevoflurane Revenue (2021-2032) & (US$ Million) Table 170. Australia Sevoflurane Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Sevoflurane Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Sevoflurane Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Sevoflurane Sales by Type (2021-2026) & (K t) Table 176. SAMEA Sevoflurane Sales by Type (2027-2032) & (K t) Table 177. SAMEA Sevoflurane Sales Price by Type (2021-2026) & (USD/Unit) Table 178. SAMEA Sevoflurane Sales Price by Type (2027-2032) & (USD/Unit) Table 179. SAMEA Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Sevoflurane Sales by Application (2021-2026) & (K t) Table 182. SAMEA Sevoflurane Sales by Application (2027-2032) & (K t) Table 183. SAMEA Sevoflurane Sales Price by Application (2021-2026) & (USD/Unit) Table 184. SAMEA Sevoflurane Sales Price by Application (2027-2032) & (USD/Unit) Table 185. SAMEA Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K t) Table 189. SAMEA Sevoflurane Sales by Country (2021-2026) & (K t) Table 190. SAMEA Sevoflurane Sales by Country (2027-2032) & (K t) Table 191. SAMEA Sevoflurane Sales Price by Country (2021-2026) & (USD/Unit) Table 192. SAMEA Sevoflurane Sales Price by Country (2027-2032) & (USD/Unit) Table 193. Brazil Sevoflurane Revenue (2021-2032) & (US$ Million) Table 194. Argentina Sevoflurane Revenue (2021-2032) & (US$ Million) Table 195. Chile Sevoflurane Revenue (2021-2032) & (US$ Million) Table 196. Colombia Sevoflurane Revenue (2021-2032) & (US$ Million) Table 197. Peru Sevoflurane Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Sevoflurane Revenue (2021-2032) & (US$ Million) Table 199. Israel Sevoflurane Revenue (2021-2032) & (US$ Million) Table 200. UAE Sevoflurane Revenue (2021-2032) & (US$ Million) Table 201. Turkey Sevoflurane Revenue (2021-2032) & (US$ Million) Table 202. Iran Sevoflurane Revenue (2021-2032) & (US$ Million) Table 203. Egypt Sevoflurane Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Sevoflurane Distributors List Table 207. Sevoflurane Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Sevoflurane Product Image Figure 2. Global Sevoflurane Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Market Size Share 2021 VS 2025 VS 2032 Figure . Generic Drug Image Figure 1. Original Drug Image Figure 2. Global Sevoflurane Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospitals Image Figure 5. Other Medical Institutions Image Figure 6. Global Sevoflurane Capacity, Capacity Utilization (2021-2032) & (K t) Figure 7. Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032 (K t) Figure 8. Global Sevoflurane Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Sevoflurane Production Market Share by Region (2021-2032) Figure 10. North America Sevoflurane Production Growth Rate (2021-2032) & (K t) Figure 11. Europe Sevoflurane Production Growth Rate (2021-2032) & (K t) Figure 12. China Sevoflurane Production Growth Rate (2021-2032) & (K t) Figure 13. Japan Sevoflurane Production Growth Rate (2021-2032) & (K t) Figure 14. Global Sevoflurane Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Sevoflurane Revenue (2021-2032) & (US$ Million) Figure 16. Global Sevoflurane Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Sevoflurane Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Sevoflurane Revenue Market Share by Region (2021-2032) Figure 19. Global Sevoflurane Sales (2021-2032) & (K t) Figure 20. Global Sevoflurane Sales by Region: 2021 VS 2025 VS 2032 (K t) Figure 21. Global Sevoflurane Sales Market Share by Region (2021-2032) Figure 22. North America Sevoflurane Sales YoY (2021-2032) & (K t) Figure 23. Europe Sevoflurane Sales YoY (2021-2032) & (K t) Figure 24. China Sevoflurane Sales YoY (2021-2032) & (K t) Figure 25. Asia (Excluding China) Sevoflurane Sales YoY (2021-2032) & (K t) Figure 26. South America, Middle East and Africa Sevoflurane Sales YoY (2021-2032) & (K t) Figure 27. Global Sevoflurane Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Sevoflurane Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Sevoflurane Revenue Market Share by Type (2021-2032) Figure 31. Global Sevoflurane Sales Market Share by Type (2021-2032) Figure 32. Global Sevoflurane Revenue Market Share by Application (2021-2032) Figure 33. Global Sevoflurane Sales Market Share by Application (2021-2032) Figure 34. North America Sevoflurane Revenue Share by Type (2021-2032) Figure 35. North America Sevoflurane Sales Share by Type (2021-2032) Figure 36. North America Sevoflurane Revenue Share by Application (2021-2032) Figure 37. North America Sevoflurane Sales Share by Application (2021-2032) Figure 38. North America Sevoflurane Revenue Share by Country (2021-2032) Figure 39. North America Sevoflurane Sales Share by Country (2021-2032) Figure 40. Europe Sevoflurane Revenue Share by Type (2021-2032) Figure 41. Europe Sevoflurane Sales Share by Type (2021-2032) Figure 42. Europe Sevoflurane Revenue Share by Application (2021-2032) Figure 43. Europe Sevoflurane Sales Share by Application (2021-2032) Figure 44. Europe Sevoflurane Revenue Share by Country (2021-2032) Figure 45. Europe Sevoflurane Sales Share by Country (2021-2032) Figure 46. China Sevoflurane Revenue Share by Type (2021-2032) Figure 47. China Sevoflurane Sales Share by Type (2021-2032) Figure 48. China Sevoflurane Revenue Share by Application (2021-2032) Figure 49. China Sevoflurane Sales Share by Application (2021-2032) Figure 50. Asia Sevoflurane Revenue Share by Type (2021-2032) Figure 51. Asia Sevoflurane Sales Share by Type (2021-2032) Figure 52. Asia Sevoflurane Revenue Share by Application (2021-2032) Figure 53. Asia Sevoflurane Sales Share by Application (2021-2032) Figure 54. Asia Sevoflurane Revenue Share by Country (2021-2032) Figure 55. Asia Sevoflurane Sales Share by Country (2021-2032) Figure 56. SAMEA Sevoflurane Revenue Share by Type (2021-2032) Figure 57. SAMEA Sevoflurane Sales Share by Type (2021-2032) Figure 58. SAMEA Sevoflurane Revenue Share by Application (2021-2032) Figure 59. SAMEA Sevoflurane Sales Share by Application (2021-2032) Figure 60. SAMEA Sevoflurane Revenue Share by Country (2021-2032) Figure 61. SAMEA Sevoflurane Sales Share by Country (2021-2032) Figure 62. Sevoflurane Value Chain Figure 63. Manufacturing Cost Structure Figure 64. Sevoflurane Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Hospitals
  • Other Medical Institutions
Companies covered
  • Abbott
  • Baxter
  • Maruishi
  • Jiangsu Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sevoflurane Market by Type
  3. 1.2.1 Global Sevoflurane Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Generic Drug
  5. 1.2.3 Original Drug
  6. 1.3 Sevoflurane Market by Application
  7. 1.3.1 Global Sevoflurane Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Other Medical Institutions
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Sevoflurane Market Dynamics
  1. 2.1 Sevoflurane Industry Trends
  2. 2.2 Sevoflurane Industry Drivers
  3. 2.3 Sevoflurane Industry Opportunities and Challenges
  4. 2.4 Sevoflurane Industry Restraints
3 Global Sevoflurane Production Overview
  1. 3.1 Global Sevoflurane Production Capacity (2021-2032)
  2. 3.2 Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Sevoflurane Production by Region
  4. 3.3.1 Global Sevoflurane Production by Region (2021-2026)
  5. 3.3.2 Global Sevoflurane Production by Region (2027-2032)
  6. 3.3.3 Global Sevoflurane Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Sevoflurane Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Sevoflurane Revenue by Region
  3. 4.2.1 Global Sevoflurane Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Sevoflurane Revenue by Region (2021-2026)
  5. 4.2.3 Global Sevoflurane Revenue by Region (2027-2032)
  6. 4.2.4 Global Sevoflurane Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Sevoflurane Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Sevoflurane Sales by Region
  9. 4.4.1 Global Sevoflurane Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Sevoflurane Sales by Region (2021-2026)
  11. 4.4.3 Global Sevoflurane Sales by Region (2027-2032)
  12. 4.4.4 Global Sevoflurane Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Sevoflurane Revenue by Manufacturers
  2. 5.1.1 Global Sevoflurane Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Sevoflurane Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Sevoflurane Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Sevoflurane Sales by Manufacturers
  6. 5.2.1 Global Sevoflurane Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Sevoflurane Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Sevoflurane Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Sevoflurane Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Sevoflurane Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Sevoflurane Manufacturers, Product Type & Application
  13. 5.7 Global Sevoflurane Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Sevoflurane Market CR5 and HHI
  16. 5.8.2 2025 Sevoflurane Tier 1, Tier 2, and Tier 3
6 Sevoflurane Market by Type
  1. 6.1 Global Sevoflurane Revenue by Type
  2. 6.1.1 Global Sevoflurane Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Sevoflurane Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Sevoflurane Sales by Type
  5. 6.2.1 Global Sevoflurane Sales by Type (2021-2032) & (K t)
  6. 6.2.2 Global Sevoflurane Sales Market Share by Type (2021-2032)
  7. 6.3 Global Sevoflurane Price by Type
7 Sevoflurane Market by Application
  1. 7.1 Global Sevoflurane Revenue by Application
  2. 7.1.1 Global Sevoflurane Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Sevoflurane Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Sevoflurane Sales by Application
  5. 7.2.1 Global Sevoflurane Sales by Application (2021-2032) & (K t)
  6. 7.2.2 Global Sevoflurane Sales Market Share by Application (2021-2032)
  7. 7.3 Global Sevoflurane Price by Application
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Sevoflurane Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Sevoflurane Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Maruishi
  14. 8.3.1 Maruishi Company Information
  15. 8.3.2 Maruishi Business Overview
  16. 8.3.3 Maruishi Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Maruishi Sevoflurane Product Portfolio
  18. 8.3.5 Maruishi Recent Developments
  19. 8.4 Jiangsu Hengrui
  20. 8.4.1 Jiangsu Hengrui Company Information
  21. 8.4.2 Jiangsu Hengrui Business Overview
  22. 8.4.3 Jiangsu Hengrui Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Sevoflurane Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Recent Developments
  25. 8.5 Lunan
  26. 8.5.1 Lunan Company Information
  27. 8.5.2 Lunan Business Overview
  28. 8.5.3 Lunan Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Lunan Sevoflurane Product Portfolio
  30. 8.5.5 Lunan Recent Developments
9 North America
  1. 9.1 North America Sevoflurane Market Size by Type
  2. 9.1.1 North America Sevoflurane Revenue by Type (2021-2032)
  3. 9.1.2 North America Sevoflurane Sales by Type (2021-2032)
  4. 9.1.3 North America Sevoflurane Price by Type (2021-2032)
  5. 9.2 North America Sevoflurane Market Size by Application
  6. 9.2.1 North America Sevoflurane Revenue by Application (2021-2032)
  7. 9.2.2 North America Sevoflurane Sales by Application (2021-2032)
  8. 9.2.3 North America Sevoflurane Price by Application (2021-2032)
  9. 9.3 North America Sevoflurane Market Size by Country
  10. 9.3.1 North America Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Sevoflurane Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Sevoflurane Market Size by Type
  2. 10.1.1 Europe Sevoflurane Revenue by Type (2021-2032)
  3. 10.1.2 Europe Sevoflurane Sales by Type (2021-2032)
  4. 10.1.3 Europe Sevoflurane Price by Type (2021-2032)
  5. 10.2 Europe Sevoflurane Market Size by Application
  6. 10.2.1 Europe Sevoflurane Revenue by Application (2021-2032)
  7. 10.2.2 Europe Sevoflurane Sales by Application (2021-2032)
  8. 10.2.3 Europe Sevoflurane Price by Application (2021-2032)
  9. 10.3 Europe Sevoflurane Market Size by Country
  10. 10.3.1 Europe Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Sevoflurane Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Sevoflurane Market Size by Type
  2. 11.1.1 China Sevoflurane Revenue by Type (2021-2032)
  3. 11.1.2 China Sevoflurane Sales by Type (2021-2032)
  4. 11.1.3 China Sevoflurane Price by Type (2021-2032)
  5. 11.2 China Sevoflurane Market Size by Application
  6. 11.2.1 China Sevoflurane Revenue by Application (2021-2032)
  7. 11.2.2 China Sevoflurane Sales by Application (2021-2032)
  8. 11.2.3 China Sevoflurane Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Sevoflurane Market Size by Type
  2. 12.1.1 Asia Sevoflurane Revenue by Type (2021-2032)
  3. 12.1.2 Asia Sevoflurane Sales by Type (2021-2032)
  4. 12.1.3 Asia Sevoflurane Price by Type (2021-2032)
  5. 12.2 Asia Sevoflurane Market Size by Application
  6. 12.2.1 Asia Sevoflurane Revenue by Application (2021-2032)
  7. 12.2.2 Asia Sevoflurane Sales by Application (2021-2032)
  8. 12.2.3 Asia Sevoflurane Price by Application (2021-2032)
  9. 12.3 Asia Sevoflurane Market Size by Country
  10. 12.3.1 Asia Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Sevoflurane Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Sevoflurane Market Size by Type
  2. 13.1.1 SAMEA Sevoflurane Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Sevoflurane Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Sevoflurane Price by Type (2021-2032)
  5. 13.2 SAMEA Sevoflurane Market Size by Application
  6. 13.2.1 SAMEA Sevoflurane Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Sevoflurane Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Sevoflurane Price by Application (2021-2032)
  9. 13.3 SAMEA Sevoflurane Market Size by Country
  10. 13.3.1 SAMEA Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Sevoflurane Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Sevoflurane Value Chain Analysis
  2. 14.1.1 Sevoflurane Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Sevoflurane Production Mode & Process
  6. 14.2 Sevoflurane Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Sevoflurane Distributors
  9. 14.2.3 Sevoflurane Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research